Emixustat hydrochloride (emixustat) is under clinical development by Acucela Inc. (Acucela) for retinal diseases including Stargardt disease (STGD). This is a rare, inherited degenerative disease of the retina … Continue reading SeaSTAR
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed